NGS Based RNA Seq Market 2027 By Product, Distribution Channel, Technology, Key Manufacturers | The Insight Partners

NGS-Based RNA-Seq Market to 2027 - Global Analysis and Forecasts By Product & Services (Sample Preparation, Sequencing Services, Sequencing Platform & Consumables and Data Analysis, Storage & Management), Technology (Sequencing by Synthesis, Nanopore Sequencing, Ion Semiconductor Sequencing and Single Molecule Real Time Sequencing), Application (Diagnostics, Drug Discovery, Precision Medicine and Others), End User (Biotechnology & Pharmaceutical Companies, Hospitals & Clinics, Research Centers and Academic & Government Institutes and Others ) and Geography

Publication Month: Jan 2019 | Report Code: TIPBT00002556 | No. of Pages: 205 | Category: Biotechnology | Status: Published

The global NGS based RNA sequencing market is expected to reach US$ 7,984.90 Mn in 2027 from US$ 1,414.59 in 2018. The market is estimated to grow with a CAGR of 19.3% from 2018-2027.

 

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant rate in Asia Pacific (APAC) region during the forecast period. The region is expected to be the fastest growing due to the key factors such as increasing investments by the respective government, growing number of the next generation sequencing workshops and conferences and development done by the companies. In addition, the introduction of the next generation sequencing based RNA sequencing based products by the companies are growing.

 

Exhibit: Lucrative Regional Markets

 

Market Insights

Reduced cost of genome sequencing

The growth in the adoption of the next generation sequencing is rising, recently in few years, next generation sequencing price have reduced greatly. For instance, first whole human genome sequencing cost over US$ 3billion in 2001 and it took approximately 15 years for its completion. However, the costs for the same in recent years has reduces to US$1,000 and the process requires less number of days. The cost of sequencing was approximately US$ 3 billion, which dropped down to US$ 10 million in 2006 and as the development in the technologies as increased the prices of sequencing has decreased to US$ 5,000 in 2012. Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing. Moreover, the increase in the service provider companies have entered the market and they are offering next generation sequencing in cheaper cost.

 

Advancements in sequencing technologies

In recent years the advancements in the next generation sequencing such as paired-end (PE) sequencing has led to produce twice the number of the reads for the same time during the library preparation. The technique involves sequencing at both the ends of DNA fragments in library and aligning the forward and reverse reads as read pairs. The techniques has also enabled sequences aligned more accurate read alignment and the ability to detect indels, which is not possible with single read data. The most recent and liked technique by the researchers is paired-end approach.

In addition, the advancement in the field of molecular biology has equally enhanced the sequencing procedures. Many industry players have come up with innovative NGS technology in last few years. For instance, Pacific Biosciences with Sequel, and Oxford Nanopore with PromethION. Additionally, three advances NSG systems that dominate the market includes Roche GS FLX (454), Illumina HiSeq 2000 (Solexa) and AB SOLiD (Agencourt).

 

Product & Services Insights

The NGS-based RNA sequencing market by product & services is segmented into sequencing platforms and consumables, sample preparation, sequencing services and data analysis, storage and management. In 2018, the sequencing platform & consumables segment held a largest market share of 38.3% of the NGS based RNA sequencing market, by product & services. This segment is also expected to dominate the market in 2027 owing to advantage which include quality of the sequence data, robustness and low noise while performing the sequence and others. Furthermore, the sample preparation segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2027.

 

End User Insights

On the basis of end user, the NGS-based RNA sequencing market is segmented into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others. In 2018, the research centers segment held a largest market share of 45.0% of the genomics market, by end user. This segment is also expected to dominate the market in 2027. However, the hospitals & clinics segment is anticipated to witness the fastest growth rate of 23.2% during the forecast period, 2018 to 2027. This higher growth rate of the segment owing to the providing the references for further researches are likely to propel the growth of the research centers and academic & government institutes segment in the coming future.

 

Exhibit: NGS-based RNA sequencing Market, by End User

 

Strategic Insights

Product & service launch/update and partnerships, agreements & collaborations were observed as the most adopted strategy in global NGS-based RNA sequencing industry. Few of the strategic developments made by the players in the market are listed below;

 

2018: In January, Illumina, Inc. launched iSeq 100 Sequencing System that delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab. 

2018: In September, QIAGEN N.V. and NeuMoDx Molecular, Inc. entered into a partnership to commercialize two new fully integrated systems for automation of PCR (polymerase chain reaction) testing.

2017: In May, QIAGEN N.V. and Maccura Biotechnology Co., Ltd. entered into a partnership to accelerate local adaptations, development and commercialization of the GeneReader NGS System in the rapidly growing clinical and clinical research markets in China.

 

NGS-BASED RNA SEQUENCING – MARKET SEGMENTATION

 

By Product

  • Sample Preparation
    • Method
      • Manual Method
      • Automated Method
    • Workflow Step
      • Library Preparation & Target Enrichment
      • Fragmentation, End Repair & Size Selection
      • Quality Control
  • Sequencing Services
  • Sequencing Platform & Consumables
  • Data Analysis, Storage & Management

By Technology

  • Sequencing By Synthesis
  • Nanopore Sequencing
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing

By Application

  • Diagnostics
  • Drug Discovery
  • Precision Medicine
  • Others

By End User

  • Hospitals & Clinics
  • Research Centers and Academic & Government Institutes
  • Biotechnology & Pharmaceutical Companies
  • Others

By Geography

•   North America

  • U.S.
  • Canada
  • Mexico

•   Europe

  • France
  • Germany
  • UK

•   Asia Pacific (APAC)

  • China
  • India
  • Japan

•   Middle East & Africa (MEA)

  • Saudi Arabia
  • South Africa
  • UAE

•   South America (SAM)

  • Brazil

 

Company Profiles

  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Pacific Biosciences of California, Inc.
  • F, Hoffman-La Roche Ltd
  • Agilent Technologies
  • BGI
  • Oxford Nanopre Technologies
  • Eurofins Scientific
  • Qiagen
  • Perkinelmer Inc.
TABLE OF CONTENTS

1. INTRODUCTION 29
1.1 SCOPE OF THE STUDY 29
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 29

2. GLOBAL NGS BASED RNA SEQ MARKET - KEY TAKEAWAYS 31

3. GLOBAL NGS BASED RNA SEQ MARKET - MARKET LANDSCAPE 34
3.1 OVERVIEW 34
3.1.1 Global NGS Based RNA Seq Market - By Product & Services 35
3.1.2 Global NGS Based RNA Seq Market - By Technology 36
3.1.3 Global NGS Based RNA Seq Market - By Application 36
3.1.4 Global NGS Based RNA Seq Market - By End User 36
3.1.5 Global NGS Based RNA Seq Market - By Geography 36
3.2 PEST ANALYSIS 37
3.2.1 North America PEST Analysis 37
3.2.2 Europe PEST Analysis 39
3.2.3 Asia Pacific PEST Analysis 41
3.2.4 Middle East & Africa PEST Analysis 43
3.2.5 South & Central America PEST Analysis 45

4. GLOBAL NGS BASED RNA SEQ MARKET - KEY MARKET DYNAMICS 47
4.1 KEY MARKET DRIVERS 47
4.1.1 Reduced Cost of Genome Sequencing 47
4.1.2 Advancements in Sequencing Technology 47
4.1.3 Next Generation Sequencing for Cancer 48
4.2 KEY MARKET RESTRAINTS 48
4.2.1 Risks Related to Genetic Data 48
4.2.2 High Cost of NGS Instruments 49
4.3 KEY MARKET OPPORTUNITIES 49
4.3.1 Application of NSG in Biomarker Discovery and Precision Medicine 49
4.3.2 Different Programs for RNA Sequencing 50
4.4 FUTURE TRENDS 50
4.4.1 Barcode Scanning for Long Reads Sequences 50
4.5 IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS 51

5. NGS BASED RNA SEQ MARKET - GLOBAL ANALYSIS 52
5.1 GLOBAL NGS BASED RNA SEQ MARKET REVENUE FORECASTS AND ANALYSIS 52
5.2 GLOBAL NGS BASED RNA SEQ MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 53
5.3 MARKET POSITIONING 54
5.4 PERFORMANCE OF KEY PLAYERS 54
5.4.1 Illumina, Inc. 54
5.4.2 Thermo Fisher Scientific Inc. 55
5.5 EXPERT OPINIONS 55

6. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY PRODUCT & SERVICES 56
6.1 OVERVIEW 56
6.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY PRODUCT & SERVICES, 2018 & 2027 (%) 56
6.3 SAMPLE PREPARATION MARKET 57
6.3.1 Overview 57
6.3.2 Global Sample Preparation Market Revenue and Forecasts to 2027 (US$ Mn) 57
6.3.3 Method Market 58
6.3.3.1 Overview 58
6.3.3.2 Manual Method Market 58
6.3.3.2.1 Overview 58
6.3.3.2.2 Global Manual Method Market Revenue and Forecasts to 2027 (US$ Mn) 59
6.3.3.3 Automated Method Market 60
6.3.3.3.1 Overview 60
6.3.3.3.2 Global Automated Method Market Revenue and Forecasts to 2027 (US$ Mn) 60
6.3.4 Workflow Step Market 61
6.3.4.1 Overview 61
6.3.4.2 Library Preparation & Target Enrichment Market 61
6.3.4.2.1 Overview 61
6.3.4.2.2 Global Library Preparation & Target Enrichment Market Revenue and Forecasts to 2027 (US$ Mn) 62
6.3.4.3 Fragmentation, End Repair & Size Selection Market 63
6.3.4.3.1 Overview 63
6.3.4.3.2 Global Fragmentation, End repair & Size Selection Market Revenue and Forecasts to 2027 (US$ Mn) 63
6.3.4.4 Quality Control Market 64
6.3.4.4.1 Overview 64
6.3.4.4.2 Global Quality Control Market Revenue and Forecasts to 2027 (US$ Mn) 64
6.4 SEQUENCING SERVICES MARKET 65
6.4.1 Overview 65
6.4.2 Global Sequencing Services Market Revenue and Forecasts to 2027 (US$ Mn) 66
6.5 SEQUENCING PLATFORM & CONSUMABLES MARKET 67
6.5.1 Overview 67
6.5.2 Global Sequencing Platform & Consumables Market Revenue and Forecasts to 2027 (US$ Mn) 68
6.6 DATA ANALYSIS, STORAGE & MANAGEMENT MARKET 69
6.6.1 Overview 69
6.6.2 Global Data Analysis, Storage & Management Market Revenue and Forecasts to 2027 (US$ Mn) 69

7. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY TECHNOLOGY 70
7.1 OVERVIEW 70
7.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY TECHNOLOGY, 2018 & 2027 (%) 70
7.3 SEQUENCING BY SYNTHESIS (SBS) MARKET 71
7.3.1 Overview 71
7.3.2 Global Sequencing By Synthesis (SBS) Market Revenue and Forecasts to 2027 (US$ Mn) 71
7.4 NANOPORE SEQUENCING MARKET 72
7.4.1 Overview 72
7.4.2 Global Nanopore Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 72
7.5 ION SEMICONDUCTOR SEQUENCING MARKET 73
7.5.1 Overview 73
7.5.2 Global Ion Semiconductor Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 73
7.6 SINGLE MOLECULE REAL TIME (SMRT) SEQUENCING MARKET 74
7.6.1 Overview 74
7.6.2 Global Single Molecule Real Time (SMRT) Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 74

8. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY APPLICATION 75
8.1 OVERVIEW 75
8.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY APPLICATION, 2018 & 2027 (%) 75
8.3 DIAGNOSTICS MARKET 76
8.3.1 Overview 76
8.3.2 Global Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn) 76
8.4 DRUG DISCOVERY MARKET 77
8.4.1 Overview 77
8.4.2 Global Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn) 77
8.5 PRECISION MEDICINE MARKET 78
8.5.1 Overview 78
8.5.2 Global Precision Medicine Market Revenue and Forecasts to 2027 (US$ Mn) 78
8.6 OTHER APPLICATIONS MARKET 79
8.6.1 Overview 79
8.6.2 Global Other Applications Market Revenue and Forecasts to 2027 (US$ Mn) 79

9. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY END USER 80
9.1 OVERVIEW 80
9.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY END USER, 2018 & 2027 (%) 80
9.3 HOSPITALS & CLINICS MARKET 81
9.3.1 Overview 81
9.3.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn) 81
9.4 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 82
9.4.1 Overview 82
9.4.2 Global Research Centers And Academic & Government Institutes Market Revenue and Forecasts to 2027 (US$ Mn) 82
9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 83
9.5.1 Overview 83
9.5.2 Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn) 83
9.6 OTHER END USERS MARKET 84
9.6.1 Overview 84
9.6.2 Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn) 84

10. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 85
10.1 OVERVIEW 85
10.2 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 86
10.3 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86
10.3.1 North America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 87
10.3.2 North America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 87
10.4 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88
10.5 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88
10.6 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89
10.7 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 89
10.8 US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 90
10.8.1 US NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 90
10.8.2 US NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 91
10.8.2.1 US Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 91
10.8.2.2 US Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 91
10.8.3 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 92
10.8.4 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 92
10.8.5 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 93
10.9 CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 94
10.9.1 Canada NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 94
10.9.2 Canada NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 95
10.9.2.1 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 95
10.9.2.2 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 95
10.9.3 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 96
10.9.4 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 96
10.9.5 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 97
10.10 MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 98
10.10.1 Mexico NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 98
10.10.2 Mexico NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 99
10.10.2.1 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 99
10.10.2.2 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 99
10.10.3 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 100
10.10.4 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 100
10.10.5 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 101

11. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 102
11.1 OVERVIEW 102
11.2 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 103
11.3 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103
11.3.1 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 104
11.3.2 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 104
11.4 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104
11.5 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105
11.6 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105
11.7 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 106
11.8 UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 107
11.8.1 UK NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 108
11.8.2 UK NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 108
11.8.2.1 UK Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 109
11.8.2.2 UK Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 109
11.8.3 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 109
11.8.4 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 110
11.8.5 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 110
11.9 GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 111
11.9.1 Germany NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 111
11.9.2 Germany NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 112
11.9.2.1 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 112
11.9.2.2 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 112
11.9.3 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 113
11.9.4 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 113
11.9.5 GERMANY NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 114
11.10 FRANCE NEXT GENERATION SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 115
11.10.1 France NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 115
11.10.2 France NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 116
11.10.2.1 France Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 116
11.10.2.2 France Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 116
11.10.3 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 117
11.10.4 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 117
11.10.5 FRANCE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 118

12. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 119
12.1 OVERVIEW 119
12.2 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 120
12.3 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120
12.3.1 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 121
12.3.2 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 121
12.4 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121
12.5 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122
12.6 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122
12.7 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 123
12.8 CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 124
12.8.1 China NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 125
12.8.2 China NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 125
12.8.2.1 China Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 126
12.8.2.2 China Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 126
12.8.3 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 126
12.8.4 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 127
12.8.5 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 127
12.9 INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 128
12.9.1 India NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 129
12.9.2 India NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 129
12.9.2.1 India Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 130
12.9.2.2 India Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 130
12.9.3 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 130
12.9.4 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 131
12.9.5 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 131
12.10 JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 132
12.10.1 Japan NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 132
12.10.2 Japan NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 133
12.10.2.1 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 133
12.10.2.2 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 133
12.10.3 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 134
12.10.4 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 134
12.10.5 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 135

13. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 136
13.1 OVERVIEW 136
13.2 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 137
13.3 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 137
13.3.1 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 138
13.3.2 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 138
13.4 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 139
13.5 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 139
13.6 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 140
13.7 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 140
13.8 SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 141
13.8.1 Saudi Arabia NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 141
13.8.2 Saudi Arabia NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 142
13.8.2.1 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 142
13.8.2.2 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 142
13.8.3 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 143
13.8.4 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 143
13.8.5 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 144
13.9 UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 145
13.9.1 UAE NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 145
13.9.2 UAE NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 146
13.9.2.1 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 146
13.9.2.2 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 146
13.9.3 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 147
13.9.4 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 147
13.9.5 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 148
13.10 SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 149
13.10.1 South Africa NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 149
13.10.2 South Africa NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 150
13.10.2.1 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 150
13.10.2.2 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 151
13.10.3 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 151
13.10.4 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 151
13.10.5 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 152

14. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 153
14.1 OVERVIEW 153
14.2 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 154
14.3 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 154
14.3.1 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 155
14.3.2 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 155
14.4 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 156
14.5 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 156
14.6 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 157
14.7 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 157
14.8 BRAZIL BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 158
14.8.1 Brazil NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 158
14.8.2 Brazil NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 159
14.8.2.1 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 159
14.8.2.2 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 159
14.8.3 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 160
14.8.4 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 160
14.8.5 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 161

15. NGS-BASED RNA-SEQ MARKET -INDUSTRY LANDSCAPE 162
15.1 OVERVIEW 162
15.2 GROWTH STRATEGIES IN THE NGS-BASED RNA-SEQ MARKET, 2016-2018 162
15.3 ORGANIC DEVELOPMENTS 162
15.3.1 Overview 162
15.4 ORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 163
15.5 PRODUCT & SERVICE LAUNCH 163
15.5.1 Recent Product & Service Launch By Players In The NGS-based RNA-seq Market 163
15.6 PRODUCT APPROVAL 164
15.6.1 Recent Product Approval By Players In The NGS-based RNA-seq Market 164
15.7 OTHERS 164
15.7.1 The NGS-based RNA-seq Market By Other Growth Strategies 164
15.8 INORGANIC DEVELOPMENTS 165
15.8.1 Overview 165
15.9 INORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 165
15.10 PARTNERSHIPS 166
15.10.1 Recent Partnerships by Players in the NGS-based RNA-seq Market 166
15.11 COLLABORATIONS 167
15.11.1 Collaborations By Players In The NGS-based RNA-seq Market 167
15.12 EXPANSION 168
15.12.1 The NGS-based RNA-seq Market By Expansion 168
15.13 ACQUISITIONS 169
15.13.1 Acquisitions By Players In The NGS-based RNA-seq Market 169
15.14 AGREEMENTS 169
15.14.1 The NGS-based RNA-seq Market By Agreements 169

16. NGS-BASED RNA-SEQ MARKET-KEY COMPANY PROFILES 170
16.1 ILLUMINA, INC. 170
16.1.1 Key Facts 170
16.1.2 Business Description 170
16.1.3 Financial Overview 171
16.1.4 Product Portfolio 171
16.1.5 Swot Analysis 172
16.1.6 Key Developments 172
16.2 THERMO FISHER SCIENTIFIC INC. 174
16.2.1 Key Facts 174
16.2.2 Business Description 174
16.2.3 Financial Overview 175
16.2.4 Product Portfolio 175
16.2.5 SWOT Analysis 176
16.2.6 Key Developments 176
16.3 PERKINELMER, INC. 177
16.3.1 Key Facts 177
16.3.2 Business Description 177
16.3.3 Financial Overview 178
16.3.4 Product Portfolio 178
16.3.5 SWOT Analysis 179
16.3.6 Key Developments 179
16.4 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 180
16.4.1 Key Facts 180
16.4.2 Business Description 180
16.4.3 Financial Information 180
16.4.4 Product Portfolio 181
16.4.5 SWOT Analysis 181
16.4.6 Key Developments 181
16.5 F. HOFFMANN-LA ROCHE LTD 182
16.5.1 Key Facts 182
16.5.2 Business Description 182
16.5.3 Financial Information 183
16.5.4 Product Portfolio 183
16.5.5 SWOT Analysis 184
16.5.6 Key Developments 184
16.6 QIAGEN 185
16.6.1 Key Facts 185
16.6.2 Business Description 185
16.6.3 Financial Information 186
16.6.4 Product Portfolio 186
16.6.5 SWOT Analysis 187
16.6.6 Key Developments 188
16.7 AGILENT TECHNOLOGIES 190
16.7.1 Key Facts 190
16.7.2 Business Description 190
16.7.3 Financial Overview 191
16.7.4 Product Portfolio 191
16.7.5 SWOT Analysis 192
16.7.6 Key Developments 192
16.8 BGI 193
16.8.1 Key Facts 193
16.8.2 Business Description 193
16.8.3 Financial Overview 193
16.8.4 Product Portfolio 193
16.8.5 SWOT Analysis 194
16.8.6 Key Developments 194
16.9 OXFORD NANOPORE TECHNOLOGIES 195
16.9.1 Key Facts 195
16.9.2 Business Description 195
16.9.3 Financial Overview 195
16.9.4 Product Portfolio 195
16.9.5 SWOT ANALYSIS 196
16.9.6 Key Developments 196
16.10 EUROFINS SCIENTIFIC 197
16.10.1 Key Facts 197
16.10.2 Business Description 197
16.10.3 Financial Overview 197
16.10.4 Product Portfolio 198
16.10.5 SWOT Analysis 198
16.10.6 Key Developments 198

17. APPENDIX 199
17.1 ABOUT THE INSIGHT PARTNERS 199
17.2 GLOSSARY OF TERMS 200
17.3 METHODOLOGY 202
17.3.1 Coverage 203
17.3.2 Secondary Research 203
17.3.3 Primary Research 204

LIST OF TABLES

TABLE 1. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86
TABLE 2. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 87
TABLE 3. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 87
TABLE 4. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88
TABLE 5. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88
TABLE 6. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89
TABLE 7. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 91
TABLE 8. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 91
TABLE 9. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 91
TABLE 10. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 92
TABLE 11. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 92
TABLE 12. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 93
TABLE 13. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 95
TABLE 14. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 95
TABLE 15. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 95
TABLE 16. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 96
TABLE 17. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 96
TABLE 18. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 97
TABLE 19. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 99
TABLE 20. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 99
TABLE 21. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 99
TABLE 22. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 100
TABLE 23. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 100
TABLE 24. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 101
TABLE 25. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103
TABLE 26. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 104
TABLE 27. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 104
TABLE 28. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104
TABLE 29. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105
TABLE 30. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105
TABLE 31. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 108
TABLE 32. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 109
TABLE 33. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 109
TABLE 34. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 109
TABLE 35. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 110
TABLE 36. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 110
TABLE 37. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 112
TABLE 38. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 112
TABLE 39. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 112
TABLE 40. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 113
TABLE 41. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 113
TABLE 42. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 114
TABLE 43. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 116
TABLE 44. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 116
TABLE 45. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 116
TABLE 46. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 117
TABLE 47. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 117
TABLE 48. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 118
TABLE 49. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120
TABLE 50. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 121
TABLE 51. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 121
TABLE 52. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121
TABLE 53. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122
TABLE 54. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122
TABLE 55. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 125
TABLE 56. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 126
TABLE 57. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 126
TABLE 58. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 126
TABLE 59. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 127
TABLE 60. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 127
TABLE 61. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 129
TABLE 62. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 130
TABLE 63. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 130
TABLE 64. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 130
TABLE 65. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 131
TABLE 66. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 131
TABLE 67. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 133
TABLE 68. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 133
TABLE 69. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 133
TABLE 70. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 134
TABLE 71. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 134
TABLE 72. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 135
TABLE 73. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 137
TABLE 74. MIDDLE EAST & AFRICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 138
TABLE 75. MIDDLE EAST & AFRICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 138
TABLE 76. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 139
TABLE 77. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 139
TABLE 78. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 140
TABLE 79. SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 142
TABLE 80. SAUDI ARABIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 142
TABLE 81. SAUDI ARABIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 142
TABLE 82. SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 143
TABLE 83. SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 143
TABLE 84. SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 144
TABLE 85. UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 146
TABLE 86. UAE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 146
TABLE 87. UAE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 146
TABLE 88. UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 147
TABLE 89. UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 147
TABLE 90. UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 148
TABLE 91. SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 150
TABLE 92. SOUTH AFRICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 150
TABLE 93. SOUTH AFRICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 151
TABLE 94. SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 151
TABLE 95. SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 151
TABLE 96. SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 152
TABLE 97. SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 154
TABLE 98. SOUTH AND CENTRAL AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 155
TABLE 99. SOUTH AND CENTRAL AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 155
TABLE 100. SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 156
TABLE 101. SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 156
TABLE 102. SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 157
TABLE 103. BRAZIL NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 159
TABLE 104. BRAZIL SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 159
TABLE 105. BRAZIL SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 159
TABLE 106. BRAZIL NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 160
TABLE 107. BRAZIL NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 160
TABLE 108. BRAZIL NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 161
TABLE 109. RECENT PRODUCT & SERVICE LAUNCH IN THE NGS-BASED RNA-SEQ MARKET 163
TABLE 110. RECENT PRODUCT APPROVAL AND ENHANCEMENTS IN THE NGS-BASED RNA-SEQ MARKET 164
TABLE 111. THE NGS-BASED RNA-SEQ MARKET BY OTHERS STRATEGIES 164
TABLE 112. RECENT PARTNERSHIPS IN THE NGS-BASED RNA-SEQ MARKET 166
TABLE 113. COLLABORATIONS IN THE NGS-BASED RNA-SEQ MARKET 167
TABLE 114. THE NGS-BASED RNA-SEQ MARKET BY EXPANSION 168
TABLE 115. ACQUISITIONS IN THE NGS-BASED RNA-SEQ MARKET 169
TABLE 116. THE NGS-BASED RNA-SEQ MARKET BY AGREEMENTS 169
TABLE 117. GLOSSARY OF TERMS, NGS BASED RNA SEQ MARKET 200

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC NGS BASED RNA SEQ MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027 31
FIGURE 2. GLOBAL NGS BASED RNA SEQ MARKET BY PRODUCT & SERVICES, MARKET SHARE (%), 2018 32
FIGURE 3. GLOBAL NGS BASED RNA SEQ MARKET BY TECHNOLOGY, MARKET SHARE (%), 2018 32
FIGURE 4. GLOBAL NGS BASED RNA SEQ MARKET BY APPLICATION, MARKET SHARE (%), 2018 33
FIGURE 5. GLOBAL NGS BASED RNA SEQ MARKET BY END USER, MARKET SHARE (%), 2018 33
FIGURE 6. NGS BASED RNA SEQ MARKET SEGMENTATION 34
FIGURE 7. NGS BASED RNA SEQ SEGMENTATION, BY REGION 35
FIGURE 8. NORTH AMERICA : PEST ANALYSIS 37
FIGURE 9. EUROPE : PEST ANALYSIS 39
FIGURE 10. ASIA - PACIFIC : PEST ANALYSIS 41
FIGURE 11. MIDDLE EAST & AFRICA : PEST ANALYSIS 43
FIGURE 12. SOUTH & CENTRAL AMERICA : PEST ANALYSIS 45
FIGURE 13. NGS BASED RNA SEQ MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 51
FIGURE 14. GLOBAL NGS BASED RNA SEQ MARKET - REVENUE FORECASTS AND ANALYSIS - 2018- 2027 52
FIGURE 15. GLOBAL NGS BASED RNA SEQ MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2018- 2027 53
FIGURE 16. GLOBAL NGS BASED RNA SEQ MARKET - KEY MARKET PLAYERS 54
FIGURE 17. GLOBAL NGS-BASED RNA SEQ MARKET BY PRODUCT & SERVICES, 2018 & 2027 (%) 56
FIGURE 18. GLOBAL SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 57
FIGURE 19. GLOBAL MANUAL METHOD MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 59
FIGURE 20. GLOBAL AUTOMATED METHOD MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 60
FIGURE 21. GLOBAL LIBRARY PREPARATION & TARGET ENRICHMENT MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 62
FIGURE 22. GLOBAL FRAGMENTATION, END REPAIR & SIZE SELECTION MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 63
FIGURE 23. GLOBAL QUALITY CONTROL MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 64
FIGURE 24. GLOBAL SEQUENCING SERVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 66
FIGURE 25. GLOBAL SEQUENCING PLATFORM & CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 68
FIGURE 26. GLOBAL DATA ANALYSIS, STORAGE & MANAGEMENT MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 69
FIGURE 27. GLOBAL NGS-BASED RNA SEQ MARKET BY TECHNOLOGY, 2018 & 2027 (%) 70
FIGURE 28. GLOBAL SEQUENCING BY SYNTHESIS (SBS) MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 71
FIGURE 29. GLOBAL NANOPORE SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 72
FIGURE 30. GLOBAL ION SEMICONDUCTOR SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 73
FIGURE 31. GLOBAL SINGLE MOLECULE REAL TIME (SMRT) SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 74
FIGURE 32. GLOBAL NGS-BASED RNA SEQ MARKET BY APPLICATION, 2018 & 2027 (%) 75
FIGURE 33. GLOBAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 76
FIGURE 34. GLOBAL DRUG DISCOVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 77
FIGURE 35. GLOBAL PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 78
FIGURE 36. GLOBAL OTHER APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 79
FIGURE 37. GLOBAL NGS-BASED RNA SEQ MARKET BY END USER, 2018 & 2027 (%) 80
FIGURE 38. GLOBAL HOSPITALS & CLINICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 81
FIGURE 39. GLOBAL RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 82
FIGURE 40. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 83
FIGURE 41. GLOBAL OTHER END USERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 84
FIGURE 42. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE, BY COUNTRY, 2018 (US$ MN) 85
FIGURE 43. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 86
FIGURE 44. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 89
FIGURE 45. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 90
FIGURE 46. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 94
FIGURE 47. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 98
FIGURE 48. EUROPE NGS BASED RNA SEQ MARKET REVENUE, BY COUNTRY, 2018 (US$ MN) 102
FIGURE 49. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 103
FIGURE 50. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 106
FIGURE 51. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 108
FIGURE 52. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 111
FIGURE 53. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 115
FIGURE 54. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE, BY COUNTRY, 2018 (US$ MN) 119
FIGURE 55. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 120
FIGURE 56. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 123
FIGURE 57. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 125
FIGURE 58. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 129
FIGURE 59. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 132
FIGURE 60. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE, BY COUNTRY, 2018 (US$ MN) 136
FIGURE 61. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 137
FIGURE 62. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 140
FIGURE 63. SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 141
FIGURE 64. UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 145
FIGURE 65. SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 149
FIGURE 66. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE, BY COUNTRY, 2018 (US$ MN) 153
FIGURE 67. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 154
FIGURE 68. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 157
FIGURE 69. BRAZIL NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 158
FIGURE 70. GROWTH STRATEGIES IN THE NGS-BASED RNA-SEQ MARKET, 2016-2018 162
FIGURE 71. ORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 163
FIGURE 72. INORGANIC DEVELOPMENTS IN THE MHEALTH MARKET, 2016-2018 165
The List of Companies

1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Pacific Biosciences of California, Inc.
4. Qaigen
5. F. Hoffmann-La Roche AG
6. Agilent Technologies, Inc.
7. BGI
8. Oxford Nanopore Technologies
9. Perkinelmer, Inc.
10. Eurofins Scientific
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the NGS Based RNA Seq market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global NGS Based RNA Seq market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution